Seattle, Washington
Colorectal cancer clinical trials in Seattle, WA
50 colorectal cancer studies are recruiting participants at sites in Seattle as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Seattle at a glance
- 50 studies are recruiting at a site in Seattle.
- By phase: Phase 1 (10), Phase 1/2 (13), Phase 2 (6), Phase 2/3 (1), Phase 3 (8), No phase (3), Observational (9). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (36), university, hospital or other (14).
- Most recent update to one of these records: November 16, 2026.
Studies recruiting in Seattle
Basic details from each study's public record (the 30 most recently updated of 50). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Study site
- Fred Hutchinson Cancer Research Center
- Registry record
- NCT06324357 · updated
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- Virginia Mason Medical Center
- Registry record
- NCT07488676 · updated
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Fred Hutchinson Cancer Center ( Site 0076)
- Registry record
- NCT06997497 · updated
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Study site
- Virginia Mason Medical Center
- Registry record
- NCT07659795 · updated
Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Solstice Oncology, Inc.
- Registry record
- NCT07808151 · updated
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Study site
- Virginia Mason Medical Center
- Registry record
- NCT07020221 · updated
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- SWOG Cancer Research Network
- Study sites
- Swedish Medical Center-Ballard Campus · Swedish Medical Center-Cherry Hill · Swedish Medical Center-First Hill
- Registry record
- NCT07018869 · updated
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- NRG Oncology
- Study sites
- FHCC at Northwest Hospital · Fred Hutchinson Cancer Center · Swedish Medical Center-First Hill
- Registry record
- NCT05174169 · updated
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Observational
- Ages 40 to 75
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study sites
- Swedish Medical Center-Ballard Campus · Swedish Medical Center-Cherry Hill · Swedish Medical Center-First Hill
- Registry record
- NCT05334069 · updated
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Wake Forest University Health Sciences
- Study sites
- Kaiser Permanente Washington · Swedish Medical Center-Ballard Campus · Swedish Medical Center-First Hill
- Registry record
- NCT06418204 · updated
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study sites
- Fred Hutchinson Cancer Research Center · Swedish Cancer Institute
- Registry record
- NCT06662786 · updated
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Swedish Cancer Institute
- Registry record
- NCT06663319 · updated
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Fred Hutchinson Cancer Research Center
- Registry record
- NCT06750094 · updated
Family Communications After Genetic Testing
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study sites
- Swedish Medical Center-Ballard Campus · Swedish Medical Center-Cherry Hill · Swedish Medical Center-First Hill
- Registry record
- NCT07143487 · updated
First-in-human Study of 7MW4911 in GI Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Study site
- Fred Hutchinson Cancer Center
- Registry record
- NCT07216560 · updated
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- University Of Washington /ID# 271298
- Registry record
- NCT06820463 · updated
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- A2 Biotherapeutics Inc.
- Study site
- Fred Hutchinson Cancer Center
- Registry record
- NCT04981119 · updated
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Artios Pharma Ltd
- Study site
- Fred Hutchinson Cancer Center / University of Washington
- Registry record
- NCT04657068 · updated
T Cell Receptor T Cells for Advanced KRAS G12V-mutant Non-small Cell Lung Cancer, Pancreas Cancer, Colon Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Fred Hutchinson Cancer Center
- Study site
- Fred Hutch/University of Washington Cancer Consortium
- Registry record
- NCT06043713 · updated
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- University Of Washington /ID# 281451
- Registry record
- NCT07525206 · updated
SMP-3124LP in Adults With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Sumitomo Pharma America, Inc.
- Study site
- University of Washington
- Registry record
- NCT06526819 · updated
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Criterium, Inc.
- Study site
- Swedish Cancer Institute
- Registry record
- NCT06992258 · updated
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Institut de Recherches Internationales Servier
- Study site
- Fred Hutchinson Cancer Research Center
- Registry record
- NCT05786924 · updated
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study sites
- Fred Hutchinson Cancer Center · Swedish Cancer Institute · Swedish Medical Center
- Registry record
- NCT07222800 · updated
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Phase 1/2
- Ages 12 and older
- All sexes
- Sponsor
- PMV Pharmaceuticals, Inc
- Study site
- University of Washington, Fred Hutchinson Cancer Center
- Registry record
- NCT04585750 · updated
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
- Study site
- Fred Hutchinson Cancer Center
- Registry record
- NCT06625775 · updated
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- Fred Hutchinson Cancer Center
- Registry record
- NCT06445062 · updated
Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- OHSU Knight Cancer Institute
- Study site
- Fred Hutch
- Registry record
- NCT05081024 · updated
A Phase 1/1b Study of IAM1363 in HER2 Cancers
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Iambic Therapeutics, Inc
- Study site
- Fred Hutchinson Cancer Center
- Registry record
- NCT06253871 · updated
Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Fred Hutchinson Cancer Center
- Study sites
- Benaroya Research Institute at Virginia Mason · Fred Hutch/University of Washington Cancer Consortium
- Registry record
- NCT06995924 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Seattle, WA on ClinicalTrials.gov.
Ask about studies near Seattle
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections